Haemonetics Corp (HAE)
94.40
+1.07
(+1.15%)
USD |
NYSE |
May 03, 16:00
94.53
+0.13
(+0.14%)
Pre-Market: 20:00
Haemonetics Cash from Operations (Quarterly): -0.54M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.54M |
| September 30, 2023 | 99.12M |
| June 30, 2023 | 19.09M |
| March 31, 2023 | 79.61M |
| December 31, 2022 | 64.42M |
| September 30, 2022 | 87.04M |
| June 30, 2022 | 41.99M |
| March 31, 2022 | 68.05M |
| December 31, 2021 | 62.43M |
| September 30, 2021 | 43.46M |
| June 30, 2021 | -1.68M |
| March 31, 2021 | 1.547M |
| December 31, 2020 | 66.29M |
| September 30, 2020 | 29.16M |
| June 30, 2020 | 11.81M |
| March 31, 2020 | 46.41M |
| December 31, 2019 | 79.28M |
| September 30, 2019 | 29.90M |
| June 30, 2019 | 2.628M |
| March 31, 2019 | 20.64M |
| December 31, 2018 | 58.16M |
| September 30, 2018 | 57.36M |
| June 30, 2018 | 23.12M |
| March 31, 2018 | 57.63M |
| December 31, 2017 | 65.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 58.90M |
| June 30, 2017 | 38.42M |
| March 31, 2017 | 34.58M |
| December 31, 2016 | 55.20M |
| September 30, 2016 | 39.26M |
| June 30, 2016 | 30.70M |
| March 31, 2016 | 53.25M |
| December 31, 2015 | 31.85M |
| September 30, 2015 | 27.51M |
| June 30, 2015 | 9.25M |
| March 31, 2015 | 55.30M |
| December 31, 2014 | 26.89M |
| September 30, 2014 | 31.24M |
| June 30, 2014 | 13.74M |
| March 31, 2014 | 51.47M |
| December 31, 2013 | 45.29M |
| September 30, 2013 | 29.36M |
| June 30, 2013 | 13.40M |
| March 31, 2013 | 27.54M |
| December 31, 2012 | 23.96M |
| September 30, 2012 | 33.01M |
| June 30, 2012 | 0.553M |
| March 31, 2012 | 33.98M |
| December 31, 2011 | 28.80M |
| September 30, 2011 | 25.41M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.68M
Minimum
Jun 2021
99.12M
Maximum
Sep 2023
43.68M
Average
43.46M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp | 204.00M |
| Becton Dickinson & Co | 515.00M |
| Boston Scientific Corp | 164.00M |
| Masimo Corp | 77.10M |
| Insulet Corp | 45.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -268.94M |
| Cash from Financing (Quarterly) | 109.43M |
| Free Cash Flow | 128.75M |
| Free Cash Flow Per Share (Quarterly) | -0.4439 |
| Free Cash Flow to Equity (Quarterly) | -131.19M |
| Free Cash Flow to Firm (Quarterly) | -21.45M |
| Free Cash Flow Yield | 2.66% |